Insights on Pharmaceuticals & Medical Products

Article

Machine learning and therapeutics 2.0: Avoiding hype, realizing potential
– Six levers can help healthcare and pharma players achieve better outcomes when using machine learning.
Article

Should sub-Saharan Africa make its own drugs?
– A comprehensive analysis of the business, economic, and public-health impact finds the potential for local production of pharmaceuticals... to be a mixed bag.
Article

Improving patient adherence through data-driven insights
– When patients fail to follow prescribed medical regimens, outcomes suffer. A McKinsey study points to areas pharmaceutical companies... can address to combat this long-standing industry issue.
Article

The European public-procurement opportunity: Delivering value in medtech
– Value-based procurement is a reality today. To capture the opportunity in today’s European medtech-public-procurement market... fully, winners need to adapt to new realities quickly.
Article

Genetic testing: Opportunities to unlock value in precision medicine
– Advanced analysis of genomic data integrated with electronic medical records and other data sets, combined with effective reimbursement... strategies and full data-regulatory compliance, will distinguish winning diagnostics companies.

Special Collections

Biopharma Frontiers:
What the future holds for the industry
Industry leaders and key stakeholders offer perspectives to inspire discussion and constructive debate.

The pharma launchpad
Ideas for pharma and biotech looking to invest for launch success.

Spotlight on Japan
As the world’s second-largest pharma and medtech market, Japan has historically been an innovation center for the industry.... But amid an evolving healthcare landscape, this collection of articles and interviews looks at what opportunities and challenges executives at life-sciences companies need to address.

Want to learn more about how we help clients in Pharmaceuticals & Medical Products?

Learn more

More insights

Article

Digitization, automation, and online testing: The future of pharma quality control
– Emerging technologies can make quality control (QC) faster and more efficient. What do pharma companies need to do to become QC... leaders?
Article

The European public-procurement opportunity: Delivering value in medtech
– Value-based procurement is a reality today. To capture the opportunity in today’s European medtech-public-procurement market... fully, winners need to adapt to new realities quickly.
Article

The rise and rise of medtech in Asia
– How can medtech companies thrive in the world’s fastest-growing market?
Interview

Building digital ecosystems in Japan
– Two Merck Healthcare digital specialists explain their company’s transformation and the impact it has had on patients.
Collection

Digital R&D: The Next Frontier for Biopharmaceuticals
– Digital promises to transform R&D productivity over the next decade. What will it take to realize this potential?
Article

Digitizing healthcare—opportunities for Germany
– Society is aging and healthcare costs keep rising. By digitizing the system, health services can be provided at lower cost and... higher quality. A new study reveals the areas for and extent of potential improvements.
Article

Developing tomorrow’s leaders in life sciences
– In a sector undergoing unprecedented change, five muscles will define the successful leaders of the future.
Article

Barriers to Digital@Scale: Shifting the focus from tech to culture
– Many pharma and medtech companies have a digital strategy. But to pull off a true digital transformation, it's crucial to focus... on culture and mindset, according to leaders who attended a recent European roundtable.
Article

R&D in the ‘age of agile’
– As innovation reshapes the pharma landscape, pharma companies will need to revisit their R&D operating models to thrive.
Report

Data driven decisions in cancer care
– EMR- and biomarker-based diagnostics are now ubiquitous in oncology. But several factors hinder greater use of automation and... analytics-driven decisions. This paper examines these limitations and suggests solutions.
Article

Change in the Japanese pharmaceutical market: Cradle of innovation or grave of corporate profits?
– Understanding structural shifts in the market can help pharma stakeholders innovate and, ultimately, deliver benefits for patients.
Sorry, we couldn't find any results. Try removing some filters.
View more

Related practices

Connect with our Pharmaceuticals & Medical Products Practice

Contact